Vefai, M. Et Al. 2012. Is CYP2C9 polymorphism associated with colorectal cancer risk?. 48th Congress of the European-Societies-of-Toxicology (EUROTOX) , (Stockholm, Sweden).

Vefai, M., Alpertunga, B., & Ozhan, G., (2012). Is CYP2C9 polymorphism associated with colorectal cancer risk? . 48th Congress of the European-Societies-of-Toxicology (EUROTOX), Stockholm, Sweden

Vefai, Mehtap, Büket ALPERTUNGA, And Gül ÖZHAN. "Is CYP2C9 polymorphism associated with colorectal cancer risk?," 48th Congress of the European-Societies-of-Toxicology (EUROTOX), Stockholm, Sweden, 2012

Vefai, Mehtap Et Al. "Is CYP2C9 polymorphism associated with colorectal cancer risk?." 48th Congress of the European-Societies-of-Toxicology (EUROTOX) , Stockholm, Sweden, 2012

Vefai, M. Alpertunga, B. And Ozhan, G. (2012) . "Is CYP2C9 polymorphism associated with colorectal cancer risk?." 48th Congress of the European-Societies-of-Toxicology (EUROTOX) , Stockholm, Sweden.

@conferencepaper{conferencepaper, author={Mehtap Vefai Et Al. }, title={Is CYP2C9 polymorphism associated with colorectal cancer risk?}, congress name={48th Congress of the European-Societies-of-Toxicology (EUROTOX)}, city={Stockholm}, country={Sweden}, year={2012}}